Loading..

The below chart reflects Mykrolis's birds-eye view on its performance with respect to its peers, the company's fillings as reported or to a similar industry, market cap, and country of origin. While Mykrolis's peer average final assessment score stands on 66.0, Mykrolis's score is 76.

Balance Sheet Analysis

Overall, Mykrolis's critical balance sheet metrics appear to signal strong support and a high likelihood of positive growth going forward. Mykrolis did a great job related to cash and cash equivalents this period, which stood at 83.6, representing a 29.2% change from the previous filing. Its impressive cash and cash equivalents metrics should support upward pressure on its's stock price. Therefore, its cash and cash equivalents movement earned a score of 92. Also, Mykrolis's price to book ratio (P/B) was reported as 2.3 and represents 8.5% change from the previous report. These book value factor numbers show that management has been prudent in focusing on efficient growth. We believe the stock price has room to grow to reflect its intrinsic value accurately. The company's book value factors component, therefore, received a grade of 79. That said, one metric, Assets, stood out as particularly concerning. Mediocre performance in terms of assets could drop the bar on expectations for Mykrolis's future attractiveness, as they changed to 348.5 in the latest filing. This works out to a 2.8% change from the last period. This unimpressive metric is weaker than its peers and competitors. Its asset component, therefore, received a grade of 53. Similarly, because the company's management is doing an excellent job managing these critical metrics, the balance sheet was given a score of 72.

The below chart describes Mykrolis's performance as reflected on its balance sheet with respect to its peers. While Mykrolis received a balance sheet score of 72, the average of its peers stands on 67.0.

Income Statement Analysis

Mykrolis appears likely to maintain its strong income statement metrics, especially EBITDA and Revenue Efficiency. Mykrolis's management did a remarkable job this period managing its EBITDA. In terms of the raw numbers, EBITDA was reported as 46.4, which represents a 1.7% change from the last period. Companies in the same industry and market capitalization are typically affected by this parameter by up to 17.8%. The company is headed in the right direction regarding EBITDA, exhibiting efficient capital controls and strong overall financial performance. The company's EBITDA movement, therefore, received a grade of 68. Also, Mykrolis did an excellent job managing its revenue efficiency this past period. Mykrolis's revenue efficiency is 296.4 according to the metrics in the current filing, which represents a 1.4% change from the previous report. This characteristic can affect companies in the same industry and market capitalization by up to 8.8%. Their industry-leading revenue efficiency makes a strong case for upward pressure on its's stock price. Consequently, their revenue efficiency received a grade of 68. However, one discouraging result, Return Factors, stood out. Mykrolis's reported return on equity (ROE) ratio was 10.5, representing a change of -4.8%. This metric might have a 5.5 percent impact on companies in the same industry and with the same market capitalization. The company's return factor metrics return on equity and return on assets are even more concerning when compared to their peers. Its return factors (ROA & ROE) components, therefore, received a grade of 58. their income statement received an overall score of 67.

The below chart describes Mykrolis's performance as reflected on its income statement with respect to its peers. While Mykrolis received a income statement score of 67 , the average of its peers stands on 60.0.

Cash Flow Analysis

Overall, Mykrolis's critical cash flow metrics appear to signal strong support and a high likelihood of positive growth going forward. Mykrolis's published asset turnover numbers were encouraging and reflected management's balanced change strategy. Mykrolis recorded asset turnover of 0.9, which represents a -2.5% change from the previous report. Companies in the same industry and market capitalization are typically affected by this parameter by up to 5.6%. Their asset turnover numbers are significantly more impressive when contrasted against their peers and competitors. The company's asset turnover movement, therefore, received a grade of 82. However, one discouraging result, Capital Expenditure, stood out. Mykrolis's management was ineffective in materially improving CapEx, which now sits at nan and represents a 0.0% change from the previous report. This performance is all the more uninspiring relative to their peers and competitors. Consequently, their CapEx movement received a grade of 68. Because their management is doing an excellent job managing these critical metrics, the cash_flow was given a score of 75.

The below chart describes Mykrolis's performance as reflected on its cash flow with respect to its peers. While Mykrolis received a cash flow score of 75, the average of its peers stands on 70.0.